Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.
Status:
Withdrawn
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if retarded phosphatidylcholine is as effective as
mesalazin in preventing an acute episode in ulcerative colitis.
The hypothesis is, that ulcerative colitis is cuased by a defect in the barrier function of
the colonic mucus. The background of the study is the finding that the phosphatidylcholine
content of the colonic mucus is reduced in patients with ulcerative colitis, in both healthy
and inflamed parts of the colon.